Home/Filings/4/0001104659-24-108964
4//SEC Filing

Gilad Oren 4

Accession 0001104659-24-108964

CIK 0001781983other

Filed

Oct 15, 8:00 PM ET

Accepted

Oct 16, 8:31 AM ET

Size

6.3 KB

Accession

0001104659-24-108964

Insider Transaction Report

Form 4
Period: 2024-10-15
Gilad Oren
DirectorPresident/CEO
Transactions
  • Purchase

    Common Stock

    2024-10-15$2.90/sh+250$725332,895 total
Holdings
  • Common Stock

    (indirect: By Daughter)
    1,200
  • Common Stock

    (indirect: By Son)
    600
Footnotes (1)
  • [F1]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Issuer

Aprea Therapeutics, Inc.

CIK 0001781983

Entity typeother

Related Parties

1
  • filerCIK 0001929300

Filing Metadata

Form type
4
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 8:31 AM ET
Size
6.3 KB